![Anna Sussman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Anna Sussman worked as the Director of Investor Relations at Pharmion Corp.
and later as the Investor Relations Contact at Clovis Oncology, Inc. from 2011 to 2023.
Former positions of Anna Sussman
| Companies | Position | End |
|---|---|---|
| CLOVIS ONCOLOGY, INC. | Public Communications Contact | 10/07/2023 |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Public Communications Contact | 15/04/2011 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
- Stock Market
- Insiders
- Anna Sussman
